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osting by EAbstract Objective: To assure the accuracy and reliability of blood pressure measurement by non-
invasive blood pressure monitor using Datascope Accutorr Plus (Paramus, NJ, USA) against
mercury manometer, among adult male participants.
Method: Eighty participants from a family physician’s ofﬁce at a teaching hospital were recruited.
One hundred and sixty measurements of blood pressure were performed according to BHS tech-
nique protocol.
Statistical analysis: Descriptive analysis was done according to the AAMI and BHS protocol
guidelines. The limits of agreement between the device and the standard were plotted using the
method of Bland and Altman plot.
Results: The mean difference ± SD between the Datascope Acutorr Plus and observer was
2.7 ± 5.2 mm Hg and 1.5 ± 3.26 mm Hg for systolic and diastolic blood pressure, respectively.
Datascope Acutorr Plus obtained A/A grading for both systolic and diastolic blood pressure.artment of Family and Com-
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2 R.A. Khawaja et al.Conclusion: Datascope Accutorr Plus (Paramus, NJ, USA) satisﬁes BHS and AAMI valida-
tion protocols for both systolic and diastolic BP and may be recommended for everyday use for
BP monitoring at home and in clinical use for adult population.
ª 2010 King Saud University. All rights reserved.1. Introduction
The purpose of blood pressure measurement is to detect any
changes from normal values, which may indicate disease. Mea-
surement is also performed to monitor the effectiveness of
medication and other methods used to control elevated blood
pressure. According to the World Health Organization report
hypertension affects about 600 million people all over world
and is one of the leading causes of cardiovascular morbidity
and mortality (The World Health Organization, 2002) and is
associated with increased risk of stroke, myocardial infarction,
congestive heart failure, peripheral vascular disease and renal
dysfunction (Murray and Lopez, 1997).
At present, European Society of Hypertension, European
Society of Cardiology and the seventh Joint National Commit-
tee guidelines stressed home blood pressure monitoring as a
supplement to the measurements in the clinic to diagnose white
coat hypertension and monitor treatment effectiveness.
The selection of a blood pressure measuring device may be
inﬂuenced by many factors, but a fundamental requirement
must be that it gives accurate measurements. Hence, British
Hypertension Society (BHS) and Association for the Advance-
ment of Medical Instrument (AAMI) have unanimously rec-
ommended that all semi-automated and automated blood
pressure devices for measuring blood pressure should be inde-
pendently validated (O’Brien et al., 2002; ANSI/AAMI SP10,
2002 Protocol, 2003).
Hundreds of automated devices are available in the market
for the measurement of blood pressure but still there is an
increasing demand and search for accurate devices (Ng and
Small, 1994). Despite widespread use of automated devices,
there is limited published evidence for their reliability and
accuracy due to the complex protocols. Out of many only
few studies conducted on the subject were according to the val-
idation protocols (de Greeff et al., 2007; Alpert, 2007).
Our main objective of the present study is the determina-
tion of the accuracy and performance of the Datascope Acu-
torr Plus before to replace the Mercury Sphygmometer to
overcome the human error and to standardize the blood pres-
sure measurement in adult male out patient clinics. We there-
fore decided to evaluate the accuracy and reliability of the
Datascope Acutorr Plus, a non-invasive oscillometric BP
monitor, using the mercury manometer reference standard
and AAMI (Association for the Advancement of Medical
Instrumentation, SP10: 2002 protocol guidelines) as well as
BHS (British Hypertension Society) validation protocol
standards.
2. Method
The Datascope Accutorr Plus (Paramus, NJ, USA) was
tested on 80 participants according to BHS and AAMI
requirements. Datascope Accutorr Plus (Paramus, NJ,
USA) is an automatic oscillometric, non-invasive BP monitorfor the arm. It is light weight, portable with user conﬁgurable
technology. Inﬂations and deﬂations are controlled by an
automatic system. It has optional infrared or predictive tem-
perature and recorder modules. The power is supplied by lith-
ium ion battery.
In this cross sectional study, 80 male adult participants of
above 30 years age were recruited from a family physician’s of-
ﬁce at King Khalid University hospital in the kingdom of Sau-
di Arabia during January–April 2009. Both Normotensive and
hypertensive but free from atrial ﬁbrillation or any sustained
arrhythmia were included in the study. Study participation
was limited to one visit. Local ethics committee approval
was obtained for the study and all 80 participants recruited
to the study were required to give written consent.
The Datascope Accutorr Plus was used to measure blood
pressure, which was either preceded or followed by auscultato-
ry measurement of blood pressure. The order of the measure-
ment was randomized so that about half of the patients had
their blood pressure measured by the auscultatory method ﬁrst
followed by the Datascope method and the remainder of the
patients had their blood pressure measured vice versa. Interval
of less than 1 min was taken between the mercury sphygmoma-
nometer and Datascope measurements. Blood pressure mea-
surements were performed by a family physician, highly
expert in BP measurement and having normal auditory as well
as visual acquity. A well maintained quality stethoscope was
used for auscultatory method of blood pressure measurement.
For all BP measurements, each participant was seated with
the back being supported for at least 5 min before measure-
ment of blood pressure. Prior to examination, patients were
advised not to talk. Blood pressure measurements were taken
from the right arm with the relaxed arm slightly ﬂexed and
placed at heart level. Cuff size was selected according to arm
circumference. Technique of BP measurements by mercury
sphygmomanometer was according to British Hypertension
Society (BHS) protocol.
2.1. Methods of validation
The principle of validation is based on the comparison between
the level of the blood pressure obtained with the reference
method, which is the mercury sphygmomanometer, and the de-
vice being validated.
To meet Advancement of Medical Instrumentation Associ-
ation (AAMI) criteria, the difference between the two devices
has to be 65 mm of mercury (mean of the values) or standard
deviation (SD) must be 68 mm Hg3 (O’Brien et al., 2002).
The British Hypertension Society has a different way to val-
idate the self measurement device: The device is classiﬁed with
grade A–D, from best to worse device. The BHS grading is
determined by calculating the percentage of differences be-
tween the device and observer that are within 5, 10 and
15 mm Hg. To meet BHS criteria devices must achieve a grade
of at least B for both systolic and diastolic measurements.
Table 1 BHS grading criteria.
Level Absolute diﬀerence between devices
[mmHg(%)]
65 610 615
A 60 85 95
B 50 75 90
C 40 65 85
D <C
Table 2 Discrepancy between Datascope Accutorr PlusTM
(device) and mercury sphygmomanometer (observer) measure-
ment for systolic blood pressure.
Absolute diﬀerence between
device and observer (mmHg)
Percentage of
diﬀerence between
the device and observer
Cumulative
percent
65 66.3 66.3
610 27.5 93.8
615 6.3 100
Table 3 Discrepancy between Datascope Accutorr PlusTM
(device) and mercury sphygmomanometer (observer) measure-
ment for diastolic blood pressure.
Absolute diﬀerence
between device and
observer (mmHg)
Percentage of
diﬀerence between
the device and observer
Cumulative
percent
65 86.3 86.3
610 11.3 97.5
615 2.5 100
Validation of Datascope Accutorr PlusTM using British Hypertension Society (BHS) and Association 3Grade A denotes greatest agreement with mercury standard
and D denotes least agreement (Table 1) (O’Brien et al., 2002).
2.2. Statistical analysis
SPSS statistical package version 16.0 was used for descriptive
analysis according to BHS and AAMI protocols of validation.
The limits of agreement between the device and the standard
were plotted using the method of Bland and Altman plot.
3. Results
The blood pressure measurements using the Datascope Accu-
torr Plus, an oscillometric monitor, was compared to mea-
surements taken using the cuff-stethoscope-mercury
sphygmomanometer technique.
Total of 160 measurements were performed on 80 partici-
pants. Participants included in the study were in blood pres-
sure range of 88–156 mmHg for systolic and 55–90 mmHg
for diastolic pressures, respectively. The systolic blood pressure
in 13 (16.2%) participants was 6100 mmHg and 6 (7.5%) par-
ticipants had measurement P150 mmHg. The diastolic mea-
surement in 14 (17.5%) participants was 660 mmHg and 5
(6.25%) participants had measurement of 90 mmHg.According to the BHS protocol the difference between
Datascope Accutorr Plus and mercury sphygmomanometer
were 66.3%, 93.8% and 100% within 5, 10 and 15 mmHg,
respectively (Table 2). Diastolic blood pressure differences
were 86.3%, 97.5% and 100% within 5, 10 and 15 mmHg,
respectively (Table 3).
Hence, according to BHS protocol guidelines, Datascope
Accutorr Plus (Paramus, NJ, USA) obtained A/A grading
for systolic as well as diastolic blood pressure.
3.1. The Bland–Altman Plot of systolic blood pressure
discrepancies between Datascope Acutorr Plus and mercury
sphygmomanometer is shown in Fig. 1
Sample size (number of patients) = 80, Difference in mean
systolic blood pressure values of two methods = 2.72,
Standard deviation = 5.2 and 95% Conﬁdence intervals
for difference in mean = 1.56–3.88. It is expected most of
the difference to lie between d  2s and d + 2s, Hence
the limits of agreement were obtained as:
Lower limit = 7.47; 95% CI = 9.46 to 5.48
Upper limit =+12.9; 95% CI = 10.93 to 14.90
The x-axis represents the average of the device and mercury
sphygmomanometer measurement, in the range 90–170 mm
Hg. The y-axis represents the difference between the device
and mercury sphygmomanometer measurements. A positive
value indicates that the device measurement is greater than
the mercury sphygmomanometer’s measurement. The bold line
shows the mean difference, and the dashed lines show the 95%
limits of agreement. Ninety-ﬁve percent of discrepancies for
systolic blood pressure were between 7.47 and +12.9 mm
Hg (2 SD) (Fig. 1).
3.2. The Bland–Altman Plot of diastolic blood pressure
discrepancies between Datascope Acutorr Plus and mercury
sphygmomanometer is shown in Fig. 2
Sample size (number of patients) = 80. Difference in mean
diastolic blood pressure values of two methods = 1.45.
Standard deviation = 3.26 and 95% Conﬁdence intervals
for difference in mean = 0.72–2.17. It is expected most of
the difference to lie between d  2s and d + 2s, Hence
the limits of agreement were obtained as:
Lower limit = 4.9; 95% CI = 6.2 to 3.7
Upper limit =+7.8; 95% CI = 6.6 to 9.1
The x-axis represents the average of the device and mercury
sphygmomanometer measurement, in the range 50–
100 mmHg. The y-axis represents the difference between the
device and mercury sphygmomanometer measurements. A po-
sitive value indicates that the device measurement is greater
than the mercury sphygmomanometer’s measurement. The
bold line shows the mean difference, and the dashed lines show
the 95% limits of agreement. Ninety-ﬁve percent of discrepan-
cies for diastolic blood pressure were between 4.9 and
+7.8 mmHg (2 SD) (Fig. 2).
To meet AAMI criteria the mean difference between the de-
vice and the mercury standard must be 65 mmHg or the stan-
dard deviation must be 68 mmHg.
In present study, the mean difference ± SD between the
Datascope Acutorr Plus and mercury sphygmomanometer
Figure 1 Bland–Altman scaterplot: Difference of systolic blood
pressure between Datascope Accutorr Plus (sys1) and mercury
sphygmomanometer (sys2).
Figure 2 Bland–Altman scaterplot: Difference of diastolic blood
pressure between Datascope Accutorr Plus (dys1) and mercury
sphygmomanometer (dys2).
4 R.A. Khawaja et al.was 2.7 ± 5.2 and 1.5 ± 3.26 mmHg for systolic and diastolic
blood pressure, respectively. Thus, in this study, Data-
scope Acutorr Plus satisﬁed AAMI protocol.
4. Discussion
In this study, analysis of 80 patients obtained using the Data-
scope oscillometric device shows that the Datascope Accutorr
Plus fulﬁls the validation protocol of BHS & AAMI and
could be replaced in clinical practice to overcome the human
error.
Several limitations of this study may be considered in inter-
preting these ﬁndings. A limitation of this study is the lack of a
strict adherence with BHS or AAMI protocols for validationdue to the complex and extremely difﬁcult to fulﬁll the condi-
tions demanded.
In this study, patient’s distribution deviated from that ex-
pected for BHS and AAMI protocols. We have lower than ex-
pected number of participants with extreme BP values. The
protocol of the AAMI needs minimum of 85 participants with
255 measurements. More than 10% of the participants were re-
quired to have a systolic blood pressure of 6100 mmHg and
P10% participants were required to have a systolic BP
P160 mmHg. More than 10% of the participants were re-
quired to have a diastolic BP of 660 mmHg andP10% partic-
ipants were required to have a diastolic BP P100 mmHg.
According to BHS protocol, minimum of 33 participants of
both sexes with a fraction of extreme BP measurements and of
three different ranges were needed and analysis was supposed
to be in different phases.
Both protocols advised 3–4 observers to measure the BP for
validation. In fact, it has been reported that recruiting partic-
ipant with extremes of BP is difﬁcult and some previous works
about BHS grading adopted modiﬁed distributions of BP sim-
ilar to this study and that work have been published and ac-
cepted by committees (Coleman et al., 2006; Braam et al.,
2002; O’Brien, 2001; Cuckson and Reinders, 2002; Jones
et al., 2000; Mee et al., 1998).
Findings of this study are comparable to those from other
studies of simultaneous measurements using different devices,
age group and clinical setups (de Greeff et al., 2007; Alpert,
2007; Zaetta et al., 2007; Wong et al., 2006; Jin et al., 2001;
Myung et al., 1987; Reinders et al., 2006; Yarows, 2007). A
numbers of reports contradict the ﬁndings of this study and
many devices have been found to be inaccurate on formal test-
ing (O’Brien et al., 1993; Coe and Houghton, 2002; Beaubien
et al., 2002; Wattigney et al., 1996; Sun et al., 1996; O’Brien
and Atkins, 1997).
In a review article, Ng and Small surveyed 423 automated
devices, of which 161 were designed for self measurement
(Ng and Small, 1994). O’Brien reported that only a fraction
of the oscillometer devices available worldwide have been inde-
pendently tested for validation according to BHS or/and
AAMI protocol and only few of them passed and recom-
mended for clinical as well as research purpose (O’Brien
et al., 2001; O’Brien, 2001).
In conclusion, despite of many devices either not tested for
validation or have been found to be inaccurate, datascope por-
table monitors are of the most popular automated devices used
in clinical practice and hypertension research. It seems that
purchasers and users are prepared to accept the word of man-
ufacturers with regard to their accuracy and performance and
to ignore warnings from the scientiﬁc literature as to their
shortcomings. I would suggest that automated devices should
be validated with particular care before to use in various stud-
ies and in clinical practice.
I also would recommend the use of Datascope Acutorr
Plus (Paramus, NJ, USA) in clinical and research settings
when accurate BP measurement is required.5. Conclusion
According to BHS validation protocol, the Datascope Accu-
torr Plus achieved an overall A/A grade with 66.3%,
93.8% and 100% of the systolic pressures and 86.3%, 97.5%
Validation of Datascope Accutorr PlusTM using British Hypertension Society (BHS) and Association 5and 100% of the diastolic pressures being within 5, 10 and
15 mmHg standards. The device also met the requirements of
the AAMI criteria with a mean difference of 2.72 ± SD
5.2 mmHg for systolic and mean difference of 1.45 ± SD
3.26 mmHg for diastolic BP respectively. The Bland Altman
plot of BP discrepancies (95% CI) between Datascope and ob-
server were between 7.5 and +12.9 mmHg (2 SD) for systolic
and between 4.9 and + 7.8 mm Hg (2 SD) for diastolic pres-
sure, respectively.
In summary, Datascope Accutorr Plus fulﬁlled the AAMI
criteria and graded A for both systolic and diastolic blood
pressure under the BHS protocol and may be recommended
for every day use for BP monitoring at home and in clinical
practice.Acknowledgment
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